645 related articles for article (PubMed ID: 3289078)
1. MR contrast enhancement of intracranial lesions with Gd-DTPA.
Hesselink JR; Press GA
Radiol Clin North Am; 1988 Jul; 26(4):873-87. PubMed ID: 3289078
[TBL] [Abstract][Full Text] [Related]
2. Paramagnetic enhancement of cerebral lesions with gadolinium-DTPA.
Hesselink JR; Dunn WM; Healy ME; Hajek P; Baker L; Brahme FJ
Acta Radiol Suppl; 1986; 369():558-60. PubMed ID: 2980556
[TBL] [Abstract][Full Text] [Related]
3. [Oral contrast media for the magnetic resonance tomography of the abdomen. A clinical trial of the tolerance for gadolinium-DTPA].
Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Felix R
Rofo; 1992 Jan; 156(1):17-23. PubMed ID: 1733470
[TBL] [Abstract][Full Text] [Related]
4. MR imaging of acute cerebral infarction: experimental study with Gd-DTPA.
Hayakawa K; Yamashita K; Matsuda T; Miyake T; Ito H
Radiat Med; 1989; 7(2):58-65. PubMed ID: 2798931
[TBL] [Abstract][Full Text] [Related]
5. Multicenter double-blind placebo-controlled study of gadopentetate dimeglumine as an MR contrast agent: evaluation in patients with cerebral lesions.
Russell EJ; Schaible TF; Dillon W; Drayer B; LiPuma J; Mancuso A; Maravilla K; Goldstein HA
AJR Am J Roentgenol; 1989 Apr; 152(4):813-23. PubMed ID: 2646872
[TBL] [Abstract][Full Text] [Related]
6. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
[TBL] [Abstract][Full Text] [Related]
7. [A comparative study between Gd-BOPTA, a biliary excretion contrast medium, and Gd-DTPA in the magnetic resonance imaging of the rat liver].
Patrizio G; Pavone P; Cardone G; Pietroletti R; Passariello R; Tettamanti E; Musu C; Felder E
Radiol Med; 1990 May; 79(5):458-62. PubMed ID: 2359853
[TBL] [Abstract][Full Text] [Related]
8. [Oral contrast media for magnetic resonance tomography of the abdomen. III. Initial patient research with gadolinium-DTPA].
Claussen C; Kornmesser W; Laniado M; Kaminsky S; Hamm B; Felix R
Rofo; 1988 Jun; 148(6):683-9. PubMed ID: 2837806
[TBL] [Abstract][Full Text] [Related]
9. Gadolinium-DTPA enhancement of experimental soft tissue carcinoma and hemorrhage in magnetic resonance imaging.
Pettersson H; Ackerman N; Kaude J; Googe RE; Mancuso AA; Scott KN; Hackett RH; Hager DA; Caballero S
Acta Radiol; 1987; 28(1):75-8. PubMed ID: 2952147
[TBL] [Abstract][Full Text] [Related]
10. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization.
Ogan MD; Schmiedl U; Moseley ME; Grodd W; Paajanen H; Brasch RC
Invest Radiol; 1987 Aug; 22(8):665-71. PubMed ID: 3667174
[TBL] [Abstract][Full Text] [Related]
11. Blood-brain barrier injury following intracarotid injection of radiographic contrast media. In vivo quantification using magnetic resonance imaging and Gd-DTPA.
Hayakawa K; Yamashita K; Mitsumori M; Nakano Y
Acta Radiol; 1990 Mar; 31(2):203-8. PubMed ID: 2372465
[TBL] [Abstract][Full Text] [Related]
12. [The enhancement effects of Gd-DTPA for cerebrospinal lesions-- comparison with conventional T2-weighted images].
Mano I; Yoshida H; Kono T; Tsuchida T; Terao H; Iio M
Rinsho Hoshasen; 1987 Dec; 32(13):1547-53. PubMed ID: 3448287
[No Abstract] [Full Text] [Related]
13. [Contrast-enhanced MR imaging using double doses of gadolinium-DTPA in evaluating brain and spinal diseases].
Matsumoto S; Hasuo K; Uchino A; Matsuura Y; Gibo M; Fukui M; Masuda K
Nihon Igaku Hoshasen Gakkai Zasshi; 1993 May; 53(5):503-10. PubMed ID: 8327315
[TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging.
Gonzalez-Scarano F; Grossman RI; Galetta S; Atlas SW; Silberberg DH
Ann Neurol; 1987 Mar; 21(3):300-6. PubMed ID: 3606036
[TBL] [Abstract][Full Text] [Related]
15. [Gadolinium DTPA in magnetic resonance. Clinical experience in intracranial pathology].
Bradac GB; Riva A; Berger T; Stura G; Duca S
Radiol Med; 1988; 76(1-2):33-7. PubMed ID: 3399707
[TBL] [Abstract][Full Text] [Related]
16. Double contrast MR imaging with iron colloid and Gd-DTPA in cholangiocellular carcinoma.
Suto Y; Shimatani Y; Kato T; Kamba M; Ohuchi Y; Kodama F; Kato T; Ohta Y
Acta Radiol; 1994 Nov; 35(6):632-3. PubMed ID: 7946691
[TBL] [Abstract][Full Text] [Related]
17. [A pharmacokinetic analysis of Gd-DTPA enhancement in MRT in breast carcinoma].
Hess T; Knopp MV; Hoffmann U; Brix G; Junkermann H; Zuna I; von Fournier D; van Kaick G
Rofo; 1994 Jun; 160(6):518-23. PubMed ID: 8011997
[TBL] [Abstract][Full Text] [Related]
18. MR Gd-DTPA enhancement of radiation brain injury.
Nishimura R; Takahashi M; Morishita S; Sumi M; Uozumi H; Sakamoto Y
Radiat Med; 1992; 10(3):109-16. PubMed ID: 1509102
[TBL] [Abstract][Full Text] [Related]
19. [3D-MR-angiography using Gd-DTPA].
Seiderer M; Bauer WM; Villringer A; Einhäupl K
Rofo; 1990 Mar; 152(3):327-32. PubMed ID: 2157258
[TBL] [Abstract][Full Text] [Related]
20. Gd-DTPA-enhanced MR imaging in mediastinal Hodgkin's disease.
Forsgren G; Nyman R; Glimelius B; Hagberg H; Rehn S; Hemmingsson A
Acta Radiol; 1994 Nov; 35(6):564-9. PubMed ID: 7946679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
